Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial
Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page
- Check2 days agoChange DetectedGlycogen storage disease II was updated to Glycogen storage disease, type II in the page's terminology (MeSH/keywords).SummaryDifference0.1%

- Check9 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to the study details or content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedRevision: v3.4.2 was added and the previous revision v3.4.1 was removed. The government-funding lapse notice was also removed.SummaryDifference0.5%

- Check52 days agoChange DetectedThe page now displays a government funding lapse notice and an updated site revision note (v3.4.1), with the previous revision (v3.4.0) removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check59 days agoChange DetectedAdditions include a glossary display and new status labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', plus 'No FEAR Act Data' and 'Revision: v3.4.0'. Deletions remove the older labels 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.3%

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.